AbCellera Biologics Inc. (ABCL)
Free
No email, no account, no signup.
Pulling latest news for AbCellera Biologics Inc.…
Bull
Bear
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99.
Get the deep 4-model report – $4.99
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
NASDAQ
Type
Biotech
Sector
Antibody discovery and development
Market Cap
$1.4B
We're already tracking AbCellera Biologics Inc. — here are the latest events we've registered
Recent News
- On April 20, 2026, AbCellera announced it will disclose interim Phase 1 results for ABCL635, an antibody therapeutic targeting menopause symptoms, during its Q1 2026 earnings call on May 11, 2026. The company is also scheduled to present at the Bank of America and Jefferies healthcare conferences in May and June 2026. These clinical updates represent the first human data from AbCellera's internal GPCR and ion channel discovery platform.
Want to know how this news affects AbCellera Biologics Inc.? Order the analysis.
Order analysis – $4.99
What you get
A complete express analysis — not just a signal. Delivered as a webpage in your account.
- Signal: BUY / HOLD / SELL — with clear reasoning
- Sentiment score 1–10 based on news, reports, and market data
- Risk score 1–10 (dilution, jurisdiction, execution)
- Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
- Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
- Upcoming catalysts with dates
- Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of AbCellera Biologics Inc. will be delivered in the same format.
Not satisfied? Get your money back within 7 days — no questions asked.
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.